Title: Tim Schwachula - Innovator in Cancer Research
Introduction
Tim Schwachula is an inventor based in Berlin, Germany. He is currently associated with Epiontis GmbH, where he focuses on innovative methods in cancer research. Although he does not hold any granted patents, his work is significant in the field of oncology.
Latest Patent Applications
Tim Schwachula has filed a patent application titled "Method for Determining Cancer Patient Survival Based on Analyzing Tumor-Infiltrating Overall T-Lymphocytes." This invention relates to a method, in vitro or in vivo, for determining cancer patient survival. It involves analyzing the number and/or amount of tumor-infiltrating overall T-lymphocytes (oTLs) based on the methylation status of at least one CpG position in one or more of the genes for CD3 γ, -δ, and -ε in a tumor sample derived from the cancer patient. A high number and/or amount of oTLs is indicative of better survival for patients with non-breast cancer, while in breast cancer, a high number and/or amount of oTLs indicates inferior survival. The invention also includes a respective kit for use in these methods.
Conclusion
Tim Schwachula's contributions to cancer research through his innovative methods highlight the importance of ongoing research in improving patient outcomes. His work at Epiontis GmbH is paving the way for future advancements in the field.